All In Biotech

Free tool

FAERS Monitor: Invokana

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 204042 or its brand name (Invokana, Canagliflozin). Reports on generic versions are filed under their own applications.

Reports

29,868

Serious

19,370

65% of reports

Hospitalization

10,749

Death reported

700

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diabetic ketoacidosis3,441
  • toe amputation2,196
  • osteomyelitis2,165
  • acute kidney injury2,008
  • fungal infection1,447
  • weight decreased1,349
  • blood glucose increased1,235
  • gangrene1,086
  • cellulitis1,036
  • nausea1,026
  • off label use1,021
  • urinary tract infection1,019
  • drug ineffective1,016
  • dizziness847
  • diabetic foot infection834

Reports by year received

View as table
YearReports
20113
20123
2013246
2014984
20157,889
20164,292
20174,362
20184,643
20192,386
20201,465
2021824
2022811
2023690
2024502
2025477
2026291

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,024,291 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
diabetic foot infectionSignal8341007.0906.4344,446
toe amputationSignal2,196535.4507.1665,185
gangreneSignal1,086154.6144.9135,768
diabetic ketoacidosisSignal3,441117.6113.6341,057
osteomyelitisSignal2,16595.591.5178,382
fungal infectionSignal1,44731.930.341,488
cellulitisSignal1,03614.813.913,035
acute kidney injurySignal2,0089.39.014,876
blood glucose increasedSignal1,2354.64.43,531
urinary tract infectionSignal1,0194.24.02,512
weight decreasedSignal1,3493.43.22,321
dizziness8471.21.128
nausea1,0260.90.99
off label use1,0210.80.841
drug ineffective1,0160.50.5417

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.